Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

1,702 public trials 177 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL

NCT04524455

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States
View all 19 locations
View Trial Details
Completed

A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving

NCT01684150

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +16 more
Locations
  • Mayo Clinic Scottsdale-Phoenix Scottsdale, Arizona, United States
  • Northwestern University Chicago, Illinois, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Duke University Health System Durham, North Carolina, United States
View Trial Details
Completed

Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)

NCT02663622

Conditions
Graft Versus Host Disease, Graft vs Host Disease, Hematologic Diseases, +6 more
Locations
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • The University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Ohio State University Columbus, Ohio, United States
View Trial Details
Completed

A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)

NCT03833180

Conditions
Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +49 more
Locations
  • City of Hope ( Site 0010) Duarte, California, United States
  • University of California - San Diego ( Site 0003) La Jolla, California, United States
  • UCLA Hematology & Oncology ( Site 0007) Los Angeles, California, United States
  • University of Nebraska Medical Center ( Site 0006) Omaha, Nebraska, United States
View all 14 locations
View Trial Details
Completed

Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")

NCT04474678

Conditions
Brain Diseases, Brain Neoplasms, Brain Tumor, +29 more
Locations
  • Rehabilitationszentrum St. Veit im Pongau Sankt Veit im Pongau, State of Salzburg, Austria
  • Kepler Universitätsklinikum Linz, Upper Austria, Austria
  • Medical University Graz Graz, Austria
  • Medical University of Vienna Vienna, Austria
View all 22 locations
View Trial Details

Related conditions